Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Hiroko Kunitake, M.D.

Co-Author

This page shows the publications co-authored by Hiroko Kunitake and David Berger.
Connection Strength

5.077
  1. The time Interval Between the End of Radiotherapy and Surgery Does Not Affect Outcomes in Rectal Cancer. Am Surg. 2021 Oct 11; 31348211047215.
    View in: PubMed
    Score: 0.248
  2. Prognosis of Different Histological Types in Patients with Stage II and III Colon Cancer. J Gastrointest Surg. 2021 Sep 09.
    View in: PubMed
    Score: 0.246
  3. Infiltrating Tumor Border Configuration is a Poor Prognostic Factor in Stage II and III Colon Adenocarcinoma. Ann Surg Oncol. 2021 Jun; 28(6):3408-3414.
    View in: PubMed
    Score: 0.232
  4. Octogenarians present with a less aggressive phenotype of colon adenocarcinoma. Surgery. 2020 12; 168(6):1138-1143.
    View in: PubMed
    Score: 0.231
  5. Ten-year survival after pathologic complete response in rectal adenocarcinoma. J Surg Oncol. 2021 Jan; 123(1):293-298.
    View in: PubMed
    Score: 0.231
  6. Adjuvant Chemotherapy Benefits on Patients with Extramural Vascular Invasion in Stages II and III Colon Cancer. J Gastrointest Surg. 2021 08; 25(8):2019-2025.
    View in: PubMed
    Score: 0.231
  7. Perineural Invasion Is a Prognostic but not a Predictive Factor in Nonmetastatic Colon Cancer. Dis Colon Rectum. 2019 10; 62(10):1212-1221.
    View in: PubMed
    Score: 0.215
  8. The impact of postoperative morbidity on survival in patients with metastatic colon and rectal cancer. J Surg Oncol. 2019 Sep; 120(3):460-472.
    View in: PubMed
    Score: 0.212
  9. Detrimental impact of symptom-detected colorectal cancer. Surg Endosc. 2020 02; 34(2):569-579.
    View in: PubMed
    Score: 0.209
  10. Impact of intramural and extramural vascular invasion on stage II-III colon cancer outcomes. J Surg Oncol. 2019 May; 119(6):749-757.
    View in: PubMed
    Score: 0.205
  11. The Impact of a Multivisceral Resection and Adjuvant Therapy in Locally Advanced Colon Cancer. J Gastrointest Surg. 2019 02; 23(2):357-366.
    View in: PubMed
    Score: 0.201
  12. A Transverse Colectomy is as Safe as an Extended Right or Left Colectomy for Mid-Transverse Colon Cancer. World J Surg. 2018 10; 42(10):3381-3389.
    View in: PubMed
    Score: 0.201
  13. Is There a Drawback of Converting a Laparoscopic Colectomy in Colon Cancer? J Surg Res. 2018 12; 232:595-604.
    View in: PubMed
    Score: 0.199
  14. Pathologic factors are more important than tumor location in long-term survival in colon cancer. Int J Colorectal Dis. 2018 Jun; 33(6):709-717.
    View in: PubMed
    Score: 0.193
  15. The Influence of Screening on Outcomes of Clinically Locally Advanced Rectal Cancer. J Gastrointest Surg. 2018 06; 22(6):1052-1058.
    View in: PubMed
    Score: 0.192
  16. Outcomes of persistent lymph node involvement after neoadjuvant therapy for stage III rectal cancer. Surgery. 2018 04; 163(4):784-788.
    View in: PubMed
    Score: 0.190
  17. Effects of local multivisceral resection for clinically locally advanced rectal cancer on long-term outcomes. J Surg Oncol. 2018 May; 117(6):1323-1329.
    View in: PubMed
    Score: 0.190
  18. The negative impact of understaging rectal cancer patients. Am J Surg. 2018 07; 216(1):93-98.
    View in: PubMed
    Score: 0.189
  19. Rectal Cancer in Patients Under 50 Years of Age. J Gastrointest Surg. 2017 Nov; 21(11):1898-1905.
    View in: PubMed
    Score: 0.186
  20. Risk Stratification for Surgical Site Infections in Colon Cancer. JAMA Surg. 2017 07 01; 152(7):686-690.
    View in: PubMed
    Score: 0.184
  21. Do packed red blood cell transfusions really worsen oncologic outcomes in colon cancer? Surgery. 2017 09; 162(3):586-591.
    View in: PubMed
    Score: 0.183
  22. The Impact of Pathologic Complete Response in Patients with Neoadjuvantly Treated Locally Advanced Rectal Cancer-a Large Single-Center Experience. J Gastrointest Surg. 2017 07; 21(7):1153-1158.
    View in: PubMed
    Score: 0.181
  23. Spatially organized multicellular immune hubs in human colorectal cancer. Cell. 2021 Sep 02; 184(18):4734-4752.e20.
    View in: PubMed
    Score: 0.061
  24. The growing trend for no primary surgery in colorectal cancer. Colorectal Dis. 2021 10; 23(10):2659-2670.
    View in: PubMed
    Score: 0.061
  25. The Use of Single-Agent Versus Multiple-Agent Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Rectal Cancer. J Gastrointest Cancer. 2021 Jul 01.
    View in: PubMed
    Score: 0.061
  26. Zip Code-Related Income Disparities in Patients with Colorectal Cancer. Am Surg. 2021 Jun 08; 31348211023435.
    View in: PubMed
    Score: 0.061
  27. Is Microsatellite Status Associated With Prognosis in Stage II Colon Cancer With High-Risk Features? Dis Colon Rectum. 2021 05; 64(5):545-554.
    View in: PubMed
    Score: 0.060
  28. Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer. Clin Cancer Res. 2021 Oct 15; 27(20):5586-5594.
    View in: PubMed
    Score: 0.060
  29. Improving staging of rectal cancer in the pelvis: the role of PET/MRI. Eur J Nucl Med Mol Imaging. 2021 04; 48(4):1235-1245.
    View in: PubMed
    Score: 0.058
  30. Impact of Single-organ Metastasis to the Liver or Lung and Genetic Mutation Status on Prognosis in Stage IV Colorectal Cancer. Clin Colorectal Cancer. 2020 03; 19(1):e8-e17.
    View in: PubMed
    Score: 0.055
  31. Addition of a scripted pre-operative patient education module to an existing ERAS pathway further reduces length of stay. Am J Surg. 2018 10; 216(4):652-657.
    View in: PubMed
    Score: 0.050
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.